DiscoverRevUp! Pharmacy PodcastEpisode 2.11 - Preventing Adverse Drug Events: The Study of Pharmacovigilance, Interview with Sara Rogers PharmD.
Episode 2.11 - Preventing Adverse Drug Events: The Study of Pharmacovigilance, Interview with Sara Rogers PharmD.

Episode 2.11 - Preventing Adverse Drug Events: The Study of Pharmacovigilance, Interview with Sara Rogers PharmD.

Update: 2021-03-09
Share

Description

The World Health Organisation has defined pharmacovigilance as "The science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other possible drug-related problem."

In this episode, we're discussing adverse drug event prevention and the study of pharmacovigilance with pharmacist and researcher Dr. Sara Rogers, PharmD, BCPS. 

Listen along as we review:

  • The current state of drug safety in the U.S. 
  • The study of pharmacovigilance
  • Prevention of adverse drug events
  • The American Society of Pharmacovigilance (ASP)
  • Pharmacogenomics
  • And more...


Guest Speaker Bio
Sara Rogers, PharmD, BCPS, is a Board Certified Pharmacotherapy Specialist (BCPT), researcher and nonprofit director. As a proponent of personalized medicine and preventing harm from medication use, she co-founded the American Society of Pharmacovigilance in 2018. Since there is a strong genetic component in the way that patients respond to medications, she has taken an active role in addressing barriers to widespread implementation of pharmacogenomics.

Dr. Rogers is a member of the Clinical Pharmacogenetics Implementation Consortium, Chairman of the Pharmacogenomics Access and Reimbursement Coalition, and an organizational member of the NIH National Human Genomics Research Institute (NHGRI) Inter-Society Coordinating Committee. She hopes these efforts will lead to improved health outcomes for patients across the US, regardless of socioeconomic status.

Additional Resources & Links
The American Society of Pharmacovigilance


Follow us on Social Media
LinkedIn
Facebook
Instagram

About Innovation Compounding

Innovation Compounding is licensed as a 503A, compounding pharmacy, accredited by The Pharmacy Compounding Accreditation Board (PCAB®).

Today, we support over 7,000 prescribers, 70,000+ patients, and annually provide 100,000+ prescriptions to 46 states across the U.S. 

We commit to individualized pharmaceutical care by being relentless in our drive for personalized medicine, compassionate toward our patients and doctors, and being a #WellnessAdvocate for our patients’ lives and state of well being.

Learn more about the work we do and how we can help to build your practice by visiting us online:

Innovation Compounding Website

Support the show
Comments 
In Channel
loading
Download from Google Play
Download from App Store
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode 2.11 - Preventing Adverse Drug Events: The Study of Pharmacovigilance, Interview with Sara Rogers PharmD.

Episode 2.11 - Preventing Adverse Drug Events: The Study of Pharmacovigilance, Interview with Sara Rogers PharmD.

Innovation Compounding